Cardiac LXR α protects against pathological cardiac hypertrophy and dysfunction by enhancing glucose uptake and utilization

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
Cardiac LXR α protects against pathological cardiac hypertrophy and dysfunction by enhancing glucose uptake and utilization ; volume:7 ; number:9 ; year:2015 ; pages:1229-1243 ; extent:15
EMBO molecular medicine / European Molecular Biology Organization ; 7, Heft 9 (2015), 1229-1243 (gesamt 15)

Creator
Cannon, Megan V.
Silljé, Herman HW
Sijbesma, Jürgen WA
Vreeswijk‐Baudoin, Inge
Ciapaite, Jolita
van der Sluis, Bart
van Deursen, Jan
Silva, Gustavo JJ
de Windt, Leon J.
Gustafsson, Jan‐Åke
van der Harst, Pim
van Gilst, Wiek H.
de Boer, Rudolf A.

DOI
10.15252/emmm.201404669
URN
urn:nbn:de:101:1-2022120208154856253817
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:39 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Cannon, Megan V.
  • Silljé, Herman HW
  • Sijbesma, Jürgen WA
  • Vreeswijk‐Baudoin, Inge
  • Ciapaite, Jolita
  • van der Sluis, Bart
  • van Deursen, Jan
  • Silva, Gustavo JJ
  • de Windt, Leon J.
  • Gustafsson, Jan‐Åke
  • van der Harst, Pim
  • van Gilst, Wiek H.
  • de Boer, Rudolf A.

Other Objects (12)

TNIP3 protects against pathological cardiac hypertrophy by stabilizing STAT1

TNIP3 protects against pathological cardiac hypertrophy by stabilizing STAT1

HIPK1 Inhibition Protects against Pathological Cardiac Hypertrophy by Inhibiting the CREB‐C/EBP β Axis

HIPK1 Inhibition Protects against Pathological Cardiac Hypertrophy by Inhibiting the CREB‐C/EBP β Axis

CYP2J2 Overexpression Protects against Arrhythmia Susceptibility in Cardiac Hypertrophy

CYP2J2 Overexpression Protects against Arrhythmia Susceptibility in Cardiac Hypertrophy

ANGPTL8 is a negative regulator in pathological cardiac hypertrophy

ANGPTL8 is a negative regulator in pathological cardiac hypertrophy

Oridonin protects against cardiac hypertrophy by promoting P21-related autophagy

Oridonin protects against cardiac hypertrophy by promoting P21-related autophagy

SUMOylation of TEAD1 Modulates the Mechanism of Pathological Cardiac Hypertrophy

SUMOylation of TEAD1 Modulates the Mechanism of Pathological Cardiac Hypertrophy

E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING

E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING

Cardiac hypertrophy at autopsy

Cardiac hypertrophy at autopsy

Glucosylceramide synthase inhibition protects against cardiac hypertrophy in chronic kidney disease

Glucosylceramide synthase inhibition protects against cardiac hypertrophy in chronic kidney disease

Histone lysine dimethyl-demethylase KDM3A controls pathological cardiac hypertrophy and fibrosis

Histone lysine dimethyl-demethylase KDM3A controls pathological cardiac hypertrophy and fibrosis

Olive oil protects against cardiac hypertrophy in D-galactose induced aging rats

Olive oil protects against cardiac hypertrophy in D-galactose induced aging rats

Improved cardiac glucose uptake : a potential mechanism for estrogens to prevent the development of cardiac hypertrophy

Hochschulschrift

Improved cardiac glucose uptake : a potential mechanism for estrogens to prevent the development of cardiac hypertrophy

Related objects